TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy
Xinyao Feng, Fangshen Li, Liangliang Zhang, Wenmo Liu, Xupu Wang, Rui Zhu, Zhen‐An Qiao, Bin Yu, Xianghui Yu
Topics & Concepts
ImmunotherapyDoxorubicinImmune systemImmunogenic cell deathCancer researchDrug deliveryMaterials scienceCancer immunotherapyTumor microenvironmentPharmacologyMedicineImmunologyChemotherapyNanotechnologyInternal medicineNanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryImmunotherapy and Immune Responses